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Abstract
 

 
-catenin–mediated Wnt signaling has been suggested to be critically involved in hematopoietic
stem cell maintenance and development of T and B cells in the immune system. Unexpectedly,
here we report that inducible Cre-loxP–mediated inactivation of the 
 

 
-catenin gene in bone
marrow progenitors does not impair their ability to self-renew and reconstitute all hematopoietic
lineages (myeloid, erythroid, and lymphoid), even in competitive mixed chimeras. In addition,
both thymocyte survival and antigen-induced proliferation of peripheral T cells is 
 

 
-catenin
independent. In contrast to earlier reports, these data exclude an essential role for 
 

 
-catenin
during hematopoiesis and lymphopoiesis.
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Introduction
 
All mature blood cells are derived from multipotent hemato-
poietic stem cells (HSCs) present in the BM (1). HSCs have
the capacity to self-renew to maintain hematopoiesis
throughout life. Both self-renewal capacity and multipotency
are lost upon differentiation to committed progenitors of
lymphoid, erythroid, and myeloid lineages. Stem cell main-
tenance and cell fate decisions of the hematopoietic system
are controlled by a handful of highly conserved develop-
mentally regulated signal transduction pathways. One of
these is the Wnt cascade, which has been shown to control
early lymphopoiesis (2) and more recently was suggested to
play a crucial role in self-renewal of HSCs (3, 4). Wnts are
secreted glycoproteins that mediate cell to cell communication
during development. They bind to the family of Frizzled
receptors (5) in a complex with the low density lipoprotein
receptor–related protein 5 and 6 (6–8). Activation of
these receptor complexes results in stabilization and accumu-
lation of a protein called 
 

 
-catenin (9). In the absence of
Wnt signaling, 
 

 
-catenin is retained in the cytoplasm in a
multiprotein complex comprising the tumor suppressor ade-
nomatous polyposis coli (APC), the scaffold protein Axin
(10, 11), and GSK-3
 

 
. In this complex 
 

 
-catenin is phos-
phorylated by GSK-3
 

 
 at its NH
 
2 
 
terminus (12) and thereby
tagged for ubiquitination and proteosomal degradation (13).
Upon activation of the Wnt pathway GSK3-
 
 
 
is inhibited
by Dishevelled (14–16) and 
 

 
-catenin can no longer be
phosphorylated at its NH
 
2 
 
terminus. Unphosphorylated
 

 
-catenin is more stable and accumulates in the cytoplasm
and translocates to the nucleus where it binds transcription
factors of the TCF/LEF family thereby activating transcrip-
tion of downstream target genes.
Evidence that Wnt proteins influence hematopoiesis and
lymphopoiesis comes from both gain and loss of function
approaches. Feeder or stromal cells overexpressing Wnt
proteins induce proliferation of cocultured human CD34
 

 
HSCs (17) and mouse pro–B cells (18), whereas purified
Wnt3A promotes the self-renewal of HSCs (4). Moreover
retroviral expression of Wnt1 and Wnt4 in fetal thymocytes
results in increased cell numbers in suspension culture (19).
In reciprocal experiments, Wnt1 and Wnt4 gene-targeted
mice show decreased thymus cellularity due to reduced pro-
liferation of immature thymocytes (20). In addition, retroviral
expression of the extracellular Wnt-binding domain of
Frizzled receptors acts in a dominant-negative fashion to
inhibit fetal liver stem cells from developing into T cells
(19). Taken together, these data show that Wnt proteins can
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modulate proliferation of hematopoietic cells and suggest
that they may also influence T cell differentiation.
Recent retroviral overexpression studies suggest that
 

 
-catenin plays a key role in HSC homeostasis (3). Thus,
overexpression of a dominant active form of 
 

 
-catenin
(lacking the NH
 
2
 
-terminal phosphorylation domain) in
HSCs led to enhanced self-renewal capacity in vitro with
preservation of stem cell markers. HSCs expressing this
construct also had increased reconstitution potential in vivo
compared with control HSCs. In contrast, HSCs trans-
duced with Axin, which negatively regulates 
 

 
-catenin by
enhancing its degradation, had reduced growth potential in
vitro as well as a drastic reduction in the ability to reconsti-
tute the hematopoietic compartment of irradiated mice.
The reciprocal outcome of these experiments led the au-
thors to suggest that 
 

 
-catenin–mediated Wnt signaling is
critical for normal HSC homeostasis.
Additional data supporting a role for Wnt signaling in
early lymphopoiesis comes from TCF1 and LEF1 gene-tar-
geted mice. T lineage cells express both TCF1 and LEF1,
whereas developing B cells express only LEF1. TCF1
gene-targeted mice have a progressive impairment in thy-
mocyte proliferation and differentiation with increasing
age, whereas fetal thymocyte development appears normal
(21–23). LEF1-deficient mice show multiple nonhemato-
poietic defects during organogenesis and die shortly after
birth (24). The lymphoid compartment of these mice ex-
hibits normal T cell development but reduced proliferation
and increased apoptosis of pro–B cells (18). Interestingly
TCF1/LEF1 double knockout mice have a much more se-
vere defect in T cell development compared with TCF1
 

 
/
 

 
mice, suggesting that TCF1 and LEF1 have partially redun-
dant functions in the thymus (23).
Although these data clearly show that components of the
Wnt signaling pathway can influence hematopoiesis and
lymphopoiesis, the presumed critical role of 
 

 
-catenin in
this process has not been tested directly under physiological
conditions. Studying the role of 
 

 
-catenin in hematopoiesis
by a conventional loss of function approach is hampered by
the fact that 
 

 
-catenin gene-targeted mice are early embry-
onic lethal (25, 26). To circumvent this problem an induc-
ible Cre-
 
loxP
 
–mediated gene targeting approach was used.
Surprisingly, inactivation of 
 

 
-catenin in BM progenitors
does not lead to any detectable perturbation in hemato-
poiesis or lymphopoiesis.
 
Materials and Methods
 
Activation of the Cre Recombinase.
 
Adult mice received five i.p.
injections of 250 
 

 
g polyI-polyC (pI-pC; Sigma-Aldrich) at 2-d
intervals. 2 d after the last injection, mice were killed and geno-
mic DNA was prepared from BM cells using standard protocols.
The deletion efficiency was assessed by Southern blot analysis of
EcoRI-digested genomic DNA hybridized with a 7,000-bp
EcoRI probe (see Fig. 1; reference 27) and quantified using a
PhosphorImager (BAS-1000; Fuji).
 
BM Chimeras.
 
CD45.1
 
 
 
C57BL/6 female mice were pur-
chased from The Jackson Laboratory. BM chimeras were pre-
pared as previously described (29). In brief, lethally irradiated
mice (1,000 rads 24 h before transfer) that had been treated i.p.
48 h previously with 100 
 

 
g anti-NK1.1 Monoclonal antibodies
were reconstituted with 10
 
7 
 
CD45.2
 
 
 

 
-catenin
 
lox/lox 
 
or 
 

 
-cat-
enin
 

 
/
 
 
 
BM for straight chimeras, or with a 1:2 mixture (5 
 
 
 
10
 
6
 
:
10 
 
 
 
10
 
6
 
) of CD45.1
 
 
 
WT and either CD45.2
 
 
 

 
-catenin
 
lox/lox
 
or 
 

 
-catenin
 

 
/
 
 
 
BM for mixed chimeras. Mice were maintained
on antibiotic (Bactrim) containing water and long-term reconsti-
tution of BM and lymphoid organs by donor-derived cells was
analyzed 3–6 mo later.
 
5- and 6-Carboxyfluorescein Diacetate Succinimidyl Ester (CFSE)
Staining.
 
Single cell suspensions were made from the spleens of
mixed BM chimeras. Cells were filtered, centrifuged, and resus-
pended at 10
 
7
 
/ml in PBS/0.1% BSA at 37
 

 
C. A total of 10 
 
 
 
10
 
7
 
splenocytes were labeled with CFSE (Molecular Probes) at a final
concentration of 5 
 

 
M and then incubated at 37
 

 
C for 10 min.
At the end of the incubation period, the cells were immediately
washed three times in cold PBS/0.1% BSA. A total of 10 
 
 
 
10
 
7
 
cells were transferred i.v. into the tail vein. 20 
 

 
g staphylococcal
enterotoxin B (SEB; Toxin Technology) was injected i.p. 1 d af-
ter cell transfer. 2 d after SEB injection the mice were killed and
splenocytes were analyzed.
 
Immunoblot Analysis.
 
Total thymocytes derived from non-
mixed BM chimeras of either control or 
 

 
-catenin
 

 
/
 
 
 
mice were
lysed in 50 
 

 
l lysis buffer (50 mM Tris, pH 8, 150 mM NaCl, 1%
Triton X-100, and 1 mM DTT containing a mixture of protease
inhibitors) for 30 min on ice and debris was removed by centrifu-
gation. 100 
 

 
g protein extracts were separated on polyacrylamide
gels, transferred to nitrocellulose, and probed with a monoclonal
antibody specific for the COOH terminus of the mouse 
 

 
-cate-
nin protein (BD Transduction Laboratories). Bound antibodies
were detected with horseradish peroxidase–conjugated secondary
antibodies (Jackson ImmunoResearch Laboratories). To ensure
that equal amounts of protein were loaded, the membrane was
reprobed with a monoclonal antibody to 
 

 
-tubulin (clone no.
B-5-1-2; Sigma-Aldrich).
 
Monoclonal Antibodies and Flow Cytometry.
 
Single cell suspen-
sions of lymphocytes from BM, thymus, and spleen were prepared
and stained using standard protocols for FACS
 
® 
 
analysis as previ-
ously described (29). Dead cells and debris were eliminated by gat-
ing on forward scatter (FSC) and side scatter (SSC). The following
monoclonal antibody conjugates were purchased from eBio-
science: CD117 (c-kit R, ACK2)-PE; CD127 (IL-7R
 
 
 
chain,
A7R34)-PE-Cy5; CD11b (M1/70)-PE-Cy5; Sca-1 (Ly-6A/E,
D7)-PE and -PE-Cy5; Ter 119-PE and PE-Cy5; B220 (RA3-
6B2)-PE-Cy5; and anti–TCR
 

 
-PE and anti–IgM-PE. Anti-
CD21 (7G6)-FITC, CD43 (S7)-FITC, CD41 (MWReg30)-
FITC, and CD23 (B3B4)-PE were purchased from BD
Biosciences. Gr-1 (Ly-6G, RB6-8C5)-FITC and -Alexa 647,
Ter 119-FITC, B220 (RA3-6B2)-FITC, CD11b-FITC, CD4
(GK1.5)-FITC, PE and APC, CD8
 
 
 
(53.6.7)-FITC and Alexa
647, CD45.2 (ALI-4A2)-FITC, -PE, and -Alexa 647, CD161
(NK1.1, PK136)-FITC and PE, CD3
 
	 
 
(145-2C11)-FITC,
CD45.1 (A20.1)-FITC, -PE, and -Alexa 647, and TCRV
 

 
8.1,2,3 (F23.1)-PE were purified from hybridoma supernatants
and conjugated in this laboratory according to standard protocols.
Alexa 647 conjugates were prepared using the appropriate Alexa
protein labeling kits (Molecular Probes). APC and PE conjugates
were prepared using kits purchased from Prozyme. Streptavidin-
APC (Molecular Probes), streptavidin PE-Cy5 (eBioscience), and
streptavidin-PE (Caltag) were used to reveal biotin conjugates.
Four-color FACS
 
® 
 
analysis (FITC, PE, PE-Cy5, and APC or Al-
exa 647) was performed using a FACSCalibur™
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(Becton Dickinson) and data was analyzed using CELLQuest™
software (Becton Dickinson). FACS
 
® 
 
sorting was performed using
a FACStar™ flow cytometer (Becton Dickinson).
 
Tissue Culture and Analysis of Thymocyte Sensitivity to Glucocorti-
coids.
 
Cells were cultured in DMEM containing 10% FCS, 2
mM glutamine, 25 mM Hepes, 100 U/ml penicillin, and 100
 

 
g/ml streptomycin. Thymocytes from mixed BM chimeras
containing both 
 

 
-catenin
 

 
/
 
 
 
(CD45.2
 

 
) and WT (CD45.1
 

 
)
cells were incubated at 3 
 
 
 
10
 
6 
 
cells/ml in 24-well plates in me-
dium alone or in medium supplemented with various concentra-
tions (10
 

 
10
 
–10
 

 
6 
 
M) of dexamethasone (Sigma-Aldrich). Cells
were collected 12 h after the addition of dexamethasone and
stained with antibodies against CD45.2, CD4, and CD8. Dead
cells were identified and gated out by 7AAD (BD Biosciences)
staining. A fixed number of beads of 6 
 

 
m in diameter (micro-
sphere standard from Bacteria Counting Kit for flow cytometry;
Molecular Probes) was added to the samples before analysis by
FACS
 
®
 
. A viable cell gate was established based on FSC and SSC
and another gate was set on the beads that could be distinguished
from cells by their different FSC and SSC. The number of viable
cells was calculated by comparing the ratio of beads to viable cells
in a given file of 2 
 
 
 
10
 
5 
 
events to a standard ratio of a sample of
known cell and bead numbers.
 
Results
 
Experimental Strategy.
 
To directly address the role of
 

 
-catenin–mediated signaling during lymphocyte develop-
ment and for hematopoiesis in general we inducibly inacti-
vated the 
 

 
-catenin gene in BM cells. Transgenic mice ex-
pressing the Cre recombinase under the control of the
IFN-inducible Mx promoter (28) were crossed to mice in
which essential portions of the 
 

 
-catenin gene are flanked
by loxP sequences (
 

 
-catenin lox/lox; Fig. 1 a; reference
27). 
 

 
-catenin lox/lox (control) and 
 

 
-catenin lox/lox and
Mx-Cre mice were treated with the IFN-
 
 
 
inducer pI-pC
five times at 2-d intervals. To assess the 
 

 
-catenin deletion
efficiency, genomic DNA of induced 
 

 
-catenin
 

 
/
 
 
 
(hereaf-
ter 
 

 
-catenin
 

 
/
 

 
) and control BM was isolated 2 d after the
last injection and analyzed by Southern blot. The deletion
efficiency in 
 

 
-catenin
 

 
/ BM was close to 100% (Fig. 1
b), as expected from previous studies(29).
Mx-Cre–induced -catenin Inactivation Results in Mortality.
Interestingly, during the time of pI-pC treatment we noted
that the -catenin/ mice had already started to lose
weight after the first injection, whereas the weight of the
injected littermate control mice remained constant (unpub-
lished data). All -catenin/ but none of the control mice
died within 23 d after the first pI-pC injection (Fig. 1 c).
Analysis of the hematopoietic compartment of a group of
-catenin/ mice just before death did not reveal any
severe anomalies (unpublished data), making the conse-
quences of inactivation of -catenin in BM cells an un-
likely cause of death. Although induction of the Mx-Cre
transgene is very efficient in the BM, its expression is not
restricted to the BM compartment as efficient inactivation
of floxed target genes is also observed in other tissues such
as the liver and the gut, which may account for the mortal-
ity of the -catenin/ mice. However, because no obvi-
ous abnormalities were observed in these tissues the cause
of death of -catenin/ mice is currently unknown.
-catenin–deficient BM Precursors Can Reconstitute All Major
Blood Lineages in BM Chimeras. The early mortality of the
-catenin/ mice precluded longitudinal analysis of the
hematopoietic compartment. However, they survived long
enough to obtain close to 100% deletion efficiency in BM
precursor cells. Therefore, CD45.1 WT lethally irradiated
mice were injected with CD45.2 control or -catenin/
Figure 1. Inducible targeting of the -catenin gene
in the BM by the Mx-Cre recombinase. (a) Schematic
representation of the -catenin protein containing an
NH2-terminal region (N-term), 12 Armadillo repeats,
and a carboxy terminus harboring the transactivation
domain (C-term). The genomic organization of the
-cateninlox/lox locus is shown with cylinders indicating
coding exons and small black rectangles indicating
noncoding exons. Exons 2–6 are flanked by two loxP
sequences (triangles). -cateninlox/lox mice were crossed
to mice carrying the IFN-–inducible Mx-Cre trans-
gene to inducibly inactivate -catenin in the BM after
pI-pC treatment. Arrows indicate approximate positions
of the PCR primers used to verify the deletion of the
floxed -catenin locus. EcoRI restriction sites and the
probe for Southern blot analysis are indicated. (b) South-
ern blot analysis of Eco-RI–digested genomic DNA
from BM of WT, -cateninlox/lox, or -catenin/
mice. The probe indicated in (a) reveals a 7-kb frag-
ment for the WT allele, two fragments of 3.8 and 3.2
kb for the homozygously floxed -catenin locus, and
one 5.2-kb fragment for the -catenin/ allele after
successful deletion of the loxP flanked gene segment.
(c) Survival curve of -cateninlox/lox and -catenin/
mice after injection of pI-pC as indicated by arrows.
Death of -catenin/ mice starts 2 wk after the last
injection. n 
 8 for both -cateninlox/lox (controls) and
-catenin/.
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BM to determine whether -catenin–deficient BM precur-
sors can reconstitute all major blood lineages. Interestingly,
BM chimeras reconstituted with -catenin–deficient BM
survived without showing any signs of hematopoietic fail-
ure. Control or -catenin–deficient BM chimeras were an-
alyzed 4 and 6 mo after transplantation. Surprisingly, all
major blood lineages in the BM such as granulocytes, mac-
rophages, megakaryocytes, early erythroblasts, or B cells
were generated from -catenin–deficient BM at compara-
ble levels to control BM (Fig. 2 a). Similarly all major thy-
mus subsets (Fig. 2 b) as well as mature T and B cells in the
spleen (Fig. 2 c) were generated normally from -catenin/
BM progenitors.
To exclude the possibility that reconstitution of the BM
chimeras is due to a few BM cells that have escaped dele-
tion, Southern blot analysis and immunoblotting using an
antibody against the carboxy-terminal portion of -catenin
was performed on total thymocytes from control and
-catenin/ chimeras. The Southern blot shows the ex-
pected pattern for the inactivated -catenin allele (Fig. 2
Figure 2. -catenin–deficient BM
reconstitutes all major hematopoietic
lineages. BM chimeras were analyzed
4–7 mo after reconstitution. (a) Absolute
donor cell numbers for total BM and
different subsets: early erythroblasts
(Early Eryth., Ter119), granulocytes
(Gran., Gr1), B cells (B220), mega-
karyocytes (Mega., CD41), and macro-
phages (Mac, Gr1 CD11b) of either
-cateninlox/lox (open bars) or -cat-
enin/ (shaded bars) mice. The bars
represent mean  SD values (n 
 5).
(b) Absolute donor cell numbers for
total thymocytes and thymocyte subsets:
CD4 CD8 (DN), CD4 CD8 (DP),
CD4 CD8 TCR (CD4), and
CD8 CD4 TCR (CD8). The bars
represent mean  SD values for -cat-
eninlox/lox (open bars) or -catenin/
(filled bars) mice, where n 
 5 for both -cateninlox/lox and -catenin/ mice. (c) Absolute donor cell numbers for total splenocytes, B cells (B220),
and T cells (CD3). n 
 5 for control and -catenin/ mice. (d) Southern blot analysis of Eco-RI–digested genomic DNA from donor thymocytes of
control (-cateninlox/lox) or -catenin/ BM chimeric mice (refer to Fig.1 a for details). (e) Immunoblot analysis of -catenin protein expression in total
donor thymocytes from control or -catenin/ BM chimeras. The blots were probed with an antiserum specific to the COOH terminus of the -catenin
protein. To verify that equal amounts of protein were loaded, the membrane was reprobed with a monoclonal antibody against -tubulin (bottom).
Figure 3. Normal development of -catenin/
hematopoietic lineages in a competitive situation.
Mixed BM chimeric mice were analyzed 4–6 mo after
reconstitution with a 1:2 mixture of WT (CD45.1)
and either -cateninlox/lox or -catenin/ (CD45.2)
BM-derived populations. (a) A representative FACS®
analysis of BM stained with anti-CD117 and anti-Sca1
gated on lin CD45.2 donor cells of either -cate-
ninlox/lox or -catenin/ mixed chimeras. Numbers indi-
cate relative percentage of HSCs (CD117 Sca1)
CLPs (CD117low Sca1low), and CMPs (CD117 Sca1)
in each indicated region. (b) Percentage HSCs, CMPs,
and CLPs gated on lin CD45.2 cells from either
-cateninlox/lox (open bars) or -catenin/ mixed chime-
ras (shaded bars). The bars represent mean  SD (n 

8). (c) Percentage early erythroblasts (Ter119), granu-
locytes (Gr1), and macrophages (Gr1 CD11b) after
gating on CD45.2 cells from either -cateninlox/lox or
-catenin/ mixed chimeras. The bars represent
mean  SD (n 
 8).
Cobas et al.225
d), and -catenin protein is only detected in thymocytes
derived from control BM cells (Fig. 2 e). No full-length
nor any truncated form of -catenin is detected in thy-
mocytes derived from -catenin/ BM cells (Fig. 2 e),
confirming that the loss of function approach for -catenin
was successful and that hematopoiesis can occur in the ab-
sence of any detectable -catenin protein.
Self-Renewal and Differentiation of -catenin–deficient BM
Precursors in a Competitive Situation. Although the BM re-
constitution suggests that all major blood lineages can in
principle be generated from -catenin–deficient progenitor
cells, it does not address the question of the reconstitution
efficiency. Thus, competitive mixed bone chimeras were
set up in which lethally irradiated WT hosts (CD45.1)
were reconstituted with either CD45.2 -catenin/ BM
or control BM, each mixed at a 2:1 ratio with CD45.1
WT BM. Chimeras were analyzed 3–5 mo later for he-
matopoietic progenitor cells, myeloid lineages, and lym-
phoid lineages derived from each donor population.
Surprisingly, the relative number of cells in phenotypi-
cally defined progenitor subsets including HSC (lin
CD117 Sca1), common myeloid progenitor (CMP; lin
CD117 Sca1), and common lymphoid progenitor (CLP;
lin CD117lo Sca1lo Il7R) within donor-derived BM was
similar in both control and -catenin–deficient chimeras
(Fig. 3, a and b). Furthermore, no differences were ob-
served in the percentages of more mature BM cell types
(including early erythroblasts, granulocytes, and macro-
phages) in -catenin/ chimeras versus control (Fig. 3 c).
The results indicate that -catenin–deficient BM progeni-
tors can self-renew and differentiate normally in the BM,
even in a competitive situation.
Competitive Lymphocyte Development from -catenin–defi-
cient BM Precursors. As defects in both B and (more se-
verely) T cell development have been reported in LEF1
and TCF1 gene-targeted mice, respectively, these two
lymphoid lineages were analyzed in more detail in mixed
BM chimeras. Flow cytometric analysis of B cell subsets in
the BM shows that the relative numbers of B220 IgM
and B220 IgM cells within the CD45.2 donor popula-
tion is similar between control and -catenin–deficient
chimeras (Fig. 4 a). Furthermore, the generation of the
more immature B220 CD43 cells defined as the pro–B
cell compartment (Hardy fraction A–C) in mixed BM chi-
meras seems not to be perturbed by the absence of -cate-
nin (Fig. 4 b).
T cell differentiation is progressively inhibited with in-
creasing age in the absence of TCF1. TCF1/ mice show
multiple developmental blocks (21) at the double negative
(DN)2 (CD44 CD25), DN4 (CD44 CD25), and im-
mature single positive (ISP; CD8 TCR) stages during
thymocyte development. Interestingly, control and
-catenin/ BM were able to reconstitute the thymus of
mixed BM chimeras to a similar extent (the chimerism for
control and -catenin/ CD45.2 thymocytes was 62 
14% and 69  19%, respectively). After gating on CD45.2
cells, all major thymic subpopulations (DN, double positive
Figure 4. Normal development of -catenin–deficient B and T cells
in mixed BM chimeras. Representative FACS® analyses (left and middle
panels) gated on CD45.2 donor cells. Bar diagrams (right panels) indi-
cate relative number  SD of the different subsets where n 
 12 for
both -cateninlox/lox (open bars) and -catenin/ (shaded bars) mice.
(a) BM stained with anti-B220 and anti-IgM antibodies. (b) BM cells
stained with anti-CD43 and anti-IgM antibodies after gating on B220
cells. (c) Total thymocytes stained with anti-CD4 and anti-CD8 anti-
bodies. DN (CD4 CD8), DP (CD4 CD8), CD4 (CD4 CD8
TCR), and CD8 (CD4 CD8 TCR). (d) Thymocytes stained
with anti-CD44 and anti-CD25 antibodies after gating on donor
(CD45.2)-derived lineage-negative cells. DN1 (CD44 CD25),
DN2 (CD44 CD25), DN3 (CD44 CD25), and DN4 (CD44
CD25). (e) CD45.2 (donor) and CD45.1 (WT) cells derived from
chimeric spleens were purified by FACS® sorting to verify deletion of
the floxed -catenin alleles after reconstitution. FACS® analysis before
(left) and after the sort (right). Relative purity of the sorted populations
are indicated. (f) Southern blot analysis of Eco-RI–digested genomic
DNA from sorted CD45.1 and CD45.2 donor splenocytes. CD45.1
cells were pooled from three different mice and CD45.2 cells are derived
from two individual mice.
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[DP], CD4 single positive, and CD8 single positive) were
present in similar percentages in both control and -cat-
enin/ chimeras (Fig. 4 c). Similarly, the more immature
thymocyte populations DN1–DN4 (defined by CD44 and
CD25 expression) were generated in similar numbers in
-catenin/ compared with control mixed BM chimeras
(Fig. 4 d). None of the expected developmental blocks at
DN2, DN4, or ISP stages were observed. To again rule out
the possibility that reconstitution in the -catenin/ mixed
BM chimeras is mediated by cells that have escaped dele-
tion, CD45.2 and CD45.1 splenocytes of these mice
were sorted and analyzed for the deletion efficiency of the
-catenin alleles. The purity of the sorted CD45.1 and
CD45.2 cells was 97 and 92%, respectively (Fig. 4 e).
Southern blot analysis shows the expected bands character-
izing the WT and inactivated alleles for the sorted
CD45.1 and CD45.2 cells, respectively (Fig. 4 f), con-
firming that T and B cells were indeed generated from
-catenin/ BM progenitors in mixed BM chimeras.
These results indicate that -catenin–deficient B cells and
thymocytes do not have a developmental disadvantage in a
competitive situation in the BM or the thymus.
Because TCF1/ thymocytes exhibit increased apopto-
sis probably due to reduced levels of Bcl-xL proteins (30),
spontaneous and glucocorticoid-induced cell death of
-catenin–deficient and WT thymocytes were analyzed.
Total thymocytes from -catenin/ and control BM chi-
meras were cultured at 37C in the presence or absence of
different concentrations of dexamethasone. The rate of
spontaneous apoptosis as well as glucocorticoid-mediated
death of DP thymocytes was similar between -catenin/
and WT chimeras (Fig. 5).
Antigen-induced Proliferation of -catenin/ Peripheral T
Cells. Because -catenin–mediated Wnt signaling influ-
ences proliferation of many different cell types, we wanted
to test whether the absence of -catenin in peripheral T
cells influences their ability to proliferate in response to anti-
gen. For this purpose peripheral T cells were isolated from
either control or -catenin/ mixed BM chimeras, labeled
with the fluorescent dye CSFE, and then transferred into re-
cipient mice. 24 h after transfer of the labeled cells the mice
were injected with SEB and proliferation of the antigen-
specific T cells was monitored 2 d after antigen challenge.
Transferring a mixed population of CD45.1 WT and
CD45.2 -catenin/ T cells derived from mixed BM chi-
meras permits a direct comparison of antigen-induced pro-
liferation of CD8 and CD4 T cells within the same
mouse. As shown in Fig. 6, antigen-specific proliferation of
CD8 V8 and CD4 V8 cells was indistinguishable be-
tween CD45.1 WT and CD45.2 -catenin–deficient
populations. The results indicate that -catenin is also dis-
pensable for antigen-induced T cell proliferation.
Discussion
To investigate the potential role of -catenin in hemato-
poiesis we made use of floxed -catenin mice (27) that ex-
press the Cre recombinase under the IFN-inducible Mx
promoter (28). Unexpectedly, -catenin–deficient BM
progenitors were able to generate all myeloid and erythroid
lineages in BM chimeras. Most surprisingly, T and B cell
development appeared normal in the absence of -catenin,
suggesting that the protein is dispensable for lymphopoiesis
as well as for hematopoiesis. Loss of function of the -cate-
nin gene was directly confirmed by the absence of -cate-
nin protein in donor thymocytes of -catenin–deficient
BM chimeras. Even when -catenin/ BM progenitor
cells were placed in a competitive situation by generating
mixed BM chimeras, they did not exhibit any detectable
developmental disadvantage.
Our data are in apparent contrast to previous studies im-
plicating -catenin as a critical protein in HSC homeostasis
(3) and in T and B cell development (for review see refer-
Figure 5. Absence of -catenin does not affect spontaneous or gluco-
corticoid-induced death of thymocytes. (a) Percentage of surviving
thymocytes gated on CD45.1 (WT donor) or CD45.2 (-catenin/
donor) derived from mixed BM chimeras after 12 h of culture at 37C.
The percentage of surviving cells is normalized to control cells maintained
at 4C. Data represent mean  SD of five experiments. (b) Glucocorticoid-
induced cell death in WT (CD45.1) and -catenin/ (CD45.2)
CD4 CD8 DP thymocytes after 12 h of culture at 37C. Data are
normalized to untreated controls and represent mean  SD from five
individual experiments.
Figure 6. Loss of -catenin does not perturb antigen-induced T cell
proliferation. CFSE-labeled splenocytes isolated from mixed BM chimeras
were transferred i.v. into WT mice. The next day mice were injected i.p.
with 20 g SEB. 2 d later the draining popliteal LNs were removed and
analyzed by FACS®. After gating on CD45.1 (WT donor) or CD45.2
(-catenin/ donor), the number of cell divisions in V8 (negative
control), CD8 V8, and CD4 V8 populations are shown. One
representative experiment out of four is shown.
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ence 2). The lack of any detectable phenotype in the he-
matopoietic compartment of -catenin/ mice is not due
to rare cells that may have escaped deletion of the floxed
-catenin gene because donor-reconstituted hematopoietic
cells in BM chimeras showed the expected pattern of de-
leted alleles. Although our floxed gene targeting strategy
could in theory allow the production of a NH2-terminal
truncated -catenin protein, we believe this to be highly
unlikely for several reasons. First, no truncated form of
-catenin was detected by Western blot in -catenin/
hematopoietic cells. Furthermore, inactivation of the same
floxed -catenin allele by other tissue-specific Cre recom-
binases (such as Wnt1-Cre, K19-Cre, or Msx2-Cre) results
not only in the lack of any detectable -catenin protein,
but also in severe developmental phenotypes. Thus, inacti-
vation of -catenin by the Wnt1-Cre transgene results in
the absence of part of the midbrain and all of the cerebel-
lum, in the lack of generation of melanoblasts and neuroge-
nin 2–dependent sensory neurons, as well as craniofacial
defects (27, 31). K19-Cre–mediated inactivation of -cate-
nin in the definitive endoderm results in the formation of
multiple hearts during embryogenesis (32) and conditional
removal of -catenin by Msx-2-Cre in ventral ectodermal
cells as well as in the apical ectodermal ridge of the devel-
oping limb leads to severe limb defects (33). These earlier
reports together with the rapid mortality reported here for
mice in which -catenin is inducibly inactivated by the
Mx-Cre transgene provide compelling evidence that suc-
cessful deletion of this floxed -catenin gene segment re-
sults in a true loss of function allele.
Why then does inactivation of -catenin in hematopoi-
etic progenitors not lead to the expected phenotypes? The
recently proposed role for -catenin in HSC homeostasis (3)
is based on studies using enriched Bcl-2 transgenic HSCs
transduced with retroviruses overexpressing either a domi-
nant active form of -catenin or axin, a known inhibitor of
the Wnt signaling pathway. Enforced expression of -cate-
nin results in an increased expansion of the HSC pool in
vitro as well as in a better reconstitution efficiency in vivo.
Overexpression of axin in HSCs leads to a reduction in both
HSC growth and reconstitution efficiency in vivo (3). This
is in contrast to our results with -catenin–deficient BM
progenitors that are able to self-renew and reconstitute the
hematopoietic compartment of lethally irradiated mice as ef-
ficiently as WT cells in mixed BM chimeras. In attempting
to reconcile these apparent discrepancies it should be noted
that overexpression of -catenin or axin in HSCs may acti-
vate (or repress) signaling pathways and target genes that are
normally not controlled by -catenin–mediated Wnt signal-
ing under physiological conditions. Similar arguments apply
to the recently described effects of constitutive -catenin ex-
pression on early thymocyte differentiation (34).
The best documented role of -catenin–mediated Wnt
signaling in the hematopoietic system is deduced from gene
targeting experiments of the two most downstream com-
ponents of the Wnt pathway, TCF1 and LEF1. These pro-
teins are HMG-box transcription factors that function as
repressors via their association with transcriptional core-
pressors of the Groucho family (35) in the absence of Wnt
signaling. TCF1-deficient mice show a progressive age-
dependent impairment of thymocyte differentiation at multi-
ple developmental stages. In particular, the highly prolifer-
ating immature thymocyte subsets such as DN2 (CD44
CD25), DN4 (CD44 CD25), and ISP (CD8 TCR)
are affected by the loss of TCF1 (21), and DP (CD4
CD8) thymocytes undergo increased apoptosis (30). In
addition, adult TCF1/ BM cells fail to reconstitute the T
cell compartment of lethally irradiated WT hosts, whereas
the development of all other blood lineages appears to be
normal (21). LEF1/ mice exhibit multiple organogenic
defects during development including lack of pelage hair,
whiskers, teeth, and functional mammary glands (24). Pro-
liferation of LEF1/ pro–B cells is reduced and an in-
creased proportion of these cells undergo apoptosis (18).
TCF1/LEF1 double knockout mice display a more severe
defect in T cell development that is characterized by a
complete block at the ISP stage and additional defects in
the DN thymocyte subsets. Transfer of TCF1//LEF1/
fetal liver cells into lethally irradiated hosts fails to reconsti-
tute the thymus (23, 36). From these studies one would ex-
pect that -catenin–deficient BM progenitor cells should
not be able to reconstitute the T cell compartment of BM
chimeras, or at least should display severe defects during
lymphocyte development. However, -catenin/ BM
progenitors reconstitute the T and B cell compartments of
mixed and nonmixed BM chimeras without obvious devel-
opmental defects, indicating that -catenin–mediated Wnt
signaling is dispensable for lymphopoiesis.
Another protein that can interact with transcription fac-
tors of the TCF/LEF1 family is plakoglobin, a close relative
of -catenin. Plakoglobin shares multiple structural features
with -catenin such as the ability to bind to E-cadherin,
APC, and Axin, as well as possessing putative NH2-terminal
GSK3 phosphorylation sites and a strong COOH-terminal
transactivation domain (37). Despite these similarities the
question of whether plakoglobin is involved in Wnt signal-
ing in vivo is very controversial. Under certain experimental
conditions plakoglobin has been shown to have similar func-
tions to -catenin. For example, plakoglobin can activate re-
porter constructs driven by promoters containing TCF/LEF
binding sites when overexpressed in cell culture (for review
see reference 37). Injection of Xenopus embryos with either
-catenin or plakoglobin mRNA mimics the phenotype
obtained by injection of Wnt1 mRNA (38), suggesting that
plakoglobin can transduce Wnt signals. However, later stud-
ies have shown that cells expressing high levels of exogenous
plakoglobin have increased levels of endogenous -catenin,
suggesting that the effects mediated by plakoglobin overex-
pression are a consequence of up-regulating the pool of sig-
naling competent -catenin (39). Importantly, plakoglobin
cannot compensate for -catenin function during embryo-
genesis as conventional and tissue-specific inactivation of
-catenin results in early embryonic death or severe abnor-
malities in the targeted tissues (25, 27, 31–33, 40). Further-
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more, expression of -catenin and plakoglobin under the
same skin-specific promoter (keratin 14 promoter) results in
completely different phenotypes (41, 42). In light of our
current knowledge we cannot formally exclude the possibil-
ity that plakoglobin, which is present at normal levels in
-catenin/ thymocytes (unpublished data), might be able
to compensate for -catenin in hematopoietic cells and thus
restore Wnt signaling. Nevertheless, such a scenario would
most likely represent a particularity of the hematopoietic sys-
tem because -catenin deficiency results in severe pheno-
types in many other tissues despite the fact that plakoglobin
is ubiquitously expressed.
Even if plakoglobin cannot substitute for -catenin, it
remains possible that Wnt signaling in the hematopoietic
compartment might be mediated by the so-called nonca-
nonical (-catenin–independent) pathway (for review see
reference 43). The mechanisms by which Wnts transduce
signals in a -catenin–independent manner are not fully un-
derstood. However, Ca2 signaling, activation of heterotri-
meric G proteins, or the JNK pathway have been shown to
be involved. Whether such noncanonical Wnt pathways are
implicated in regulating hematopoiesis and/or lymphopoie-
sis in -catenin–deficient mice remains to be investigated.
If, on the other hand, Wnt signaling is truly abolished in
the absence of -catenin, other Wnt-independent func-
tions of TCF1 and LEF1 during lymphopoiesis must be
considered. In this scenario the functions of TCF and LEF1
would differ between hematopoietic cells and epithelial
cells. In epithelial cells they would mediate Wnt-induced
signaling via the canonical -catenin–dependent pathway,
whereas in hematopoietic cells TCF1 and LEF1 would
rather exert -catenin–independent functions such as (but
not restricted to) spatial organization of T cell–specific en-
hancers (44) or transcriptional repression through their in-
teraction with Groucho proteins (35). Based on the pheno-
types of TCF1- and LEF1-deficient mice, these putative
novel functions of TCF1 and LEF1 would presumably in-
tersect preferentially with pathways that are important for
lymphocyte proliferation and/or survival. The fact that
transgenic expression of Bcl-2 in thymocytes partially res-
cues TCF1 deficiency (30) is consistent with such a model.
In conclusion, and in contrast to prevailing views, our
data indicate that -catenin is dispensable for hematopoiesis
and lymphopoiesis under physiological conditions. Never-
theless, they in no way preclude the possibility that the
Wnt signaling pathway might be manipulated to achieve
therapeutic goals in the hematopoietic system, as suggested
by others (3, 4, 45).
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